Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001008315-03-000003
Filing Date
2003-07-10
Accepted
2003-07-10 12:29:43
Documents
1
Period of Report
2003-02-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 5369
  Complete submission text file 0001008315-03-000003.txt   7221
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address MYRIAD GENETICS INC 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address MYRIAD GENETICS INC 320 WAKARA WAY SALT LAKE CITY UT 84108 8015843600
SKOLNICK MARK H (Reporting) CIK: 0001008315 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26642 | Film No.: 03781458